Lyra Therapeutics (LYRA) Non Operating Income (2019 - 2025)
Lyra Therapeutics (LYRA) recorded Non Operating Income of $169,000 in Q4 2025, down 61.1% from $435,000 a year earlier and down 34.0% from the prior quarter.
Powered by 
Analysis
Lyra Therapeutics (LYRA) Non Operating Income (2019 - 2025) Analysis & Trends
For FY2025, Lyra Therapeutics reported Non Operating Income of $2.11 million, down 28.4% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 91.5% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $2.95 million in FY2024 (-34.4%), $4.5 million in FY2023 (+332.2%), $1.04 million in FY2022 (+920.6%) and $102,000 in FY2021 (+24.4%).
- The Q4 2025 figure is the lowest quarterly Non Operating Income since Q3 2022.
- On a year-over-year basis, Non Operating Income rose in two of the last eight quarters, with an average decline of 31.1%.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 420.0% in Q2 2021, against a decline of 72.6% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $256,000 (Q3 2025), $1.39 million (Q2 2025) and $298,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lyra Therapeutics | 354,976.41 | 354,976.41 | - | 169,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 435,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 855,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 933,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 34,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 26,000.00 |
| Mar 31, 2021 | 29,000.00 |
API Access
Lyra Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LYRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LYRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LYRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();